These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 15758071)

  • 1. Long-term in vivo provision of antigen-specific T cell immunity by programming hematopoietic stem cells.
    Yang L; Baltimore D
    Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4518-23. PubMed ID: 15758071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes.
    Serra P; Amrani A; Han B; Yamanouchi J; Thiessen SJ; Santamaria P
    Proc Natl Acad Sci U S A; 2002 Nov; 99(24):15566-71. PubMed ID: 12432095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transplantation of mouse HSCs genetically modified to express a CD4-restricted TCR results in long-term immunity that destroys tumors and initiates spontaneous autoimmunity.
    Ha SP; Klemen ND; Kinnebrew GH; Brandmaier AG; Marsh J; Hangoc G; Palmer DC; Restifo NP; Cornetta K; Broxmeyer HE; Touloukian CE
    J Clin Invest; 2010 Dec; 120(12):4273-88. PubMed ID: 21084750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-15 induces type 1 and type 2 CD4+ and CD8+ T cells proliferation but is unable to drive cytokine production in the absence of TCR activation or IL-12 / IL-4 stimulation in vitro.
    Niedbala W; Wei X; Liew FY
    Eur J Immunol; 2002 Feb; 32(2):341-7. PubMed ID: 11807773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonspecific CD4(+) T cells with uptake of antigen-specific dendritic cell-released exosomes stimulate antigen-specific CD8(+) CTL responses and long-term T cell memory.
    Hao S; Yuan J; Xiang J
    J Leukoc Biol; 2007 Oct; 82(4):829-38. PubMed ID: 17626150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface expression of heat shock protein gp96 enhances cross-presentation of cellular antigens and the generation of tumor-specific T cell memory.
    Dai J; Liu B; Caudill MM; Zheng H; Qiao Y; Podack ER; Li Z
    Cancer Immun; 2003 Jan; 3():1. PubMed ID: 12747743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine dendritic cells transfected with human GP100 elicit both antigen-specific CD8(+) and CD4(+) T-cell responses and are more effective than DNA vaccines at generating anti-tumor immunity.
    Yang S; Vervaert CE; Burch J; Grichnik J; Seigler HF; Darrow TL
    Int J Cancer; 1999 Nov; 83(4):532-40. PubMed ID: 10508491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y; Zhang J; Mi Z; Robbins P; Falo LD
    J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization with a lentiviral vector stimulates both CD4 and CD8 T cell responses to an ovalbumin transgene.
    Rowe HM; Lopes L; Ikeda Y; Bailey R; Barde I; Zenke M; Chain BM; Collins MK
    Mol Ther; 2006 Feb; 13(2):310-9. PubMed ID: 16275163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapy of established tumors using bone marrow transplantation with antigen gene--modified hematopoietic stem cells.
    Cui Y; Kelleher E; Straley E; Fuchs E; Gorski K; Levitsky H; Borrello I; Civin CI; Schoenberger SP; Cheng L; Pardoll DM; Whartenby KA
    Nat Med; 2003 Jul; 9(7):952-8. PubMed ID: 12778137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional reconstitution of class II MHC-restricted T cell immunity mediated by retroviral transfer of the alpha beta TCR complex.
    Fujio K; Misaki Y; Setoguchi K; Morita S; Kawahata K; Kato I; Nosaka T; Yamamoto K; Kitamura T
    J Immunol; 2000 Jul; 165(1):528-32. PubMed ID: 10861092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The immunogenicity of dendritic cell-based vaccines is not hampered by doxorubicin and melphalan administration.
    Casati A; Zimmermann VS; Benigni F; Bertilaccio MT; Bellone M; Mondino A
    J Immunol; 2005 Mar; 174(6):3317-25. PubMed ID: 15749863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
    Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
    Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dendritic cells charged with apoptotic tumor cells induce long-lived protective CD4+ and CD8+ T cell immunity against B16 melanoma.
    Goldszmid RS; Idoyaga J; Bravo AI; Steinman R; Mordoh J; Wainstok R
    J Immunol; 2003 Dec; 171(11):5940-7. PubMed ID: 14634105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An adenoviral vector cancer vaccine that delivers a tumor-associated antigen/CD40-ligand fusion protein to dendritic cells.
    Zhang L; Tang Y; Akbulut H; Zelterman D; Linton PJ; Deisseroth AB
    Proc Natl Acad Sci U S A; 2003 Dec; 100(25):15101-6. PubMed ID: 14645711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Introduction of exogenous T-cell receptors into human hematopoietic progenitors results in exclusion of endogenous T-cell receptor expression.
    Vatakis DN; Arumugam B; Kim SG; Bristol G; Yang O; Zack JA
    Mol Ther; 2013 May; 21(5):1055-63. PubMed ID: 23481324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential kinetics of antigen dependency of CD4+ and CD8+ T cells.
    Rabenstein H; Behrendt AC; Ellwart JW; Naumann R; Horsch M; Beckers J; Obst R
    J Immunol; 2014 Apr; 192(8):3507-17. PubMed ID: 24639353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functionally mature CD4 and CD8 TCRalphabeta cells are generated in OP9-DL1 cultures from human CD34+ hematopoietic cells.
    Van Coppernolle S; Verstichel G; Timmermans F; Velghe I; Vermijlen D; De Smedt M; Leclercq G; Plum J; Taghon T; Vandekerckhove B; Kerre T
    J Immunol; 2009 Oct; 183(8):4859-70. PubMed ID: 19801512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NKT and CD8 lymphocytes mediate suppression of hepatocellular carcinoma growth via tumor antigen-pulsed dendritic cells.
    Shibolet O; Alper R; Zlotogarov L; Thalenfeld B; Engelhardt D; Rabbani E; Ilan Y
    Int J Cancer; 2003 Aug; 106(2):236-43. PubMed ID: 12800200
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.